Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Employment agrmnt
Appointed director
Acq. announced
Quarterly results
Director departure
|
|
ChromaDex Corp. (CDXC)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
8-K
| Investor presentation, Quarterly results |
| 08/10/2022 |
8-K
| Quarterly results |
| 05/12/2022 |
8-K
| Quarterly results |
| 11/03/2021 |
8-K
| Investor presentation, Quarterly results |
| 08/03/2021 |
8-K
| Investor presentation, Quarterly results |
| 05/06/2021 |
8-K
| Quarterly results |
| 11/04/2020 |
8-K
| Investor presentation, Quarterly results|
Docs:
|
"Sep. 30, 2019 Sales, net $14,180 $12,053 Cost of sales 5,726 5,304 Gross profit 8,454 6,749 Operating expenses: Sales and marketing 5,223 4,626 Research and development 880 1,044 General and administrative 6,547 7,967 Operating expenses 12,650 13,637 Operating loss Nonoperating expense: Interest expense, net Nonoperating expense Net loss $ $ Basic and diluted loss per common share $ $ Basic and diluted weighted average common shares outstanding 61,695 57,658 See Notes to Consolidated Financial Statements in Part I of ChromaDex's Quarterly Report on Form 10-Q filed with Securities and Exchange Commission on November 4, 2020.",
"PRESENTATION" |
|
| 08/06/2020 |
8-K
| Quarterly results |
| 05/11/2020 |
8-K
| Quarterly results |
| 11/12/2019 |
8-K
| Quarterly results |
| 08/07/2019 |
8-K
| Quarterly results |
| 05/09/2019 |
8-K
| Investor presentation, Quarterly results|
Docs:
|
"Mar. 31, 2018 Sales, net $10,048 $6,567 Cost of sales 4,747 3,430 Gross profit 5,301 3,137 Operating expenses: Sales and marketing 4,174 3,269 Research and development 1,168 1,439 General and administrative 8,331 6,828 Operating expenses 13,673 11,536 Operating loss Nonoperating income : Interest income , net 35 Nonoperating income : 35 Net loss $ $ Basic and diluted loss per common share $ $ Basic and diluted weighted average common shares outstanding 55,325 54,858 See Notes to Condensed Consolidated Financial Statements in Part I of ChromaDex's Quarterly Report on Form 10-Q filed with Securities and Exchange Commission on May 9, 2019. ChromaDex Corporation and Subsidiaries Condensed Consolidated Balance Sheets March 31, 2019 and December 31, 2018 Mar. 31, 2019 Dec. 31, 2018 Assets Curre...",
"Investor Presentation of ChromaDex Corporation" |
|
| 11/07/2018 |
8-K
| Investor presentation, Quarterly results|
Docs:
|
"Sep. 30, 2017 Sales, net $8,120 $6,084 Cost of sales 3,759 3,169 Gross profit 4,361 2,915 Operating expenses: Sales and marketing 4,837 1,103 Research and development 1,350 1,040 General and administrative 6,770 3,948 Operating expenses 12,957 6,091 Operating loss Nonoperating expense: Interest expense, net Nonoperating expenses Loss from continuing operations Loss from discontinued operations - Gain on sale of discontinued operations - 5,467 Income from discontinued operations - 5,358 Net income $ $2,137 Basic earnings per common share: Loss from continuing operations $ $ Earnings from discontinued operations $- $0.12 Basic earnings per common share $ $0.05 Diluted earnings per common share: Loss from continuing operations $ $ Earnings from discontinued operations $- $0.11 Diluted ear...",
"Investor Presentation of ChromaDex Corporation" |
|
| 05/10/2018 |
8-K
| Investor presentation, Quarterly results|
Docs:
|
"ChromaDex Corporation and Subsidiaries Condensed Consolidated Statements of Operations Three Month Periods Ended March 31, 2018 and April 1, 2017 Q1 2017 Sales, net $6,567 $3,368 Cost of sales 3,430 1,750 Gross profit 3,137 1,618 Operating expenses: Sales and marketing 3,269 405 Research and development 1,439 664 General and administrative 6,828 2,322 Operating expenses 11,536 3,391 Operating loss Nonoperating expense: Interest expense, net Nonoperating expenses Loss from continuing operations Loss from discontinued operations - Net loss $ $ Basic and diluted loss per common share: Loss from continuing operations $ $ Loss from discontinued operations $- $ Basic and diluted loss per common share $ $ Basic and diluted weighted average common shares outstanding 54,858 38,031 See Notes to ...",
"INVESTOR PRESENTATION" |
|
| 11/09/2017 |
8-K
| Quarterly results |
| 08/10/2017 |
8-K
| Quarterly results|
Docs:
|
"Q2 2017 Q2 2016 Q2 2017 Q2 2016 Q2 2017 Q2 2016 Sales $5,306,855 $8,829,579 Sales $- $- Sales $5,306,855 $8,829,579 Cost of sales 3,044,086 4,702,132 Cost of sales Cost of sales 2,945,711 4,634,723 Gross profit 2,262,769 4,127,447 Gross profit 98,375 67,409 Gross profit 2,361,144 4,194,856 Operating expenses: Operating expenses: Operating expenses: Sales and marketing 728,299 698,031 Sales and marketing - - Sales and marketing 728,299 698,031 Research and development 849,962 751,726 Research and development - - Research and development 849,962 751,726 General and administrative 2,657,573 2,306,559 General and administrative General and administrative 2,155,355 1,936,398 Other 745,773 - Other - - Other 745,773 - Operating expenses 4,981,607 3,756,316 Operating expenses Operating expenses..." |
|
| 05/11/2017 |
8-K
| Quarterly results|
Docs:
|
"April 2, 2016 Sales, net $4,449,122 $7,331,945 Cost of sales 2,696,469 3,880,526 Gross profit 1,752,653 3,451,419 Operating expenses: Sales and marketing 596,162 544,722 Research and development 664,190 464,072 General and administrative 2,383,146 1,988,559 Operating expenses 3,643,498 2,997,353 Operating income 454,066 Nonoperating income : Interest income 2 794 Interest expense Nonoperating expenses Income before income taxes 266,365 Provision for income taxes - Net income $ $255,625 Basic earnings per common share $ $0.01 Diluted earnings per common share $ $0.01 Basic weighted average common shares outstanding 38,030,688 36,414,041 Diluted weighted average common shares outstanding 38,030,688 37,472,579 See Notes to Condensed Consolidated Financial Statements in Part I of ChromaDex'..." |
|
| 03/16/2017 |
8-K
| Form 8-K - Current report |
| 11/10/2016 |
8-K
| Form 8-K - Current report |
| 08/11/2016 |
8-K
| Quarterly results |
|
|